{"id":269126,"date":"2025-10-01T12:14:15","date_gmt":"2025-10-01T12:14:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/269126\/"},"modified":"2025-10-01T12:14:15","modified_gmt":"2025-10-01T12:14:15","slug":"gene-solutions-and-ampath-launch-advanced-genomics-laboratory-in-hyderabad-to-expand-access-to-precision-medicine-in-india","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/269126\/","title":{"rendered":"Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India"},"content":{"rendered":"<p> HYDERABAD, India, Oct. 1, 2025 \/PRNewswire\/ &#8212; <a href=\"https:\/\/genesolutions.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Gene Solutions<\/a>, a leading genetic testing innovator in Asia, has partnered\u00a0with <a href=\"https:\/\/ampath.com\/hyderabad\" target=\"_blank\" rel=\"nofollow noopener\">AMPATH<\/a> (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims\u00a0to bring high-value, next-generation sequencing (NGS) technologies closer to patients and healthcare providers across the country.<\/p>\n<p>    &#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<\/p>\n<p>          <a href=\"#\" class=\"tabfocus\" role=\"button\"><img title=\"Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions (sixth from left), and Dr. Maneesh Bagai, COO of AMPATH (standing to his right), exchange the signed Memorandum of Understanding (MOU).\" data-getimg=\"https:\/\/mma.prnewswire.com\/media\/2786650\/Dr_Nguyen_Hoai_Nghia_Co_founder_CEO_Gene_Solutions__sixth_left.jpg?w=400\" id=\"imageid_2\" alt=\"Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions (sixth from left), and Dr. Maneesh Bagai, COO of AMPATH (standing to his right), exchange the signed Memorandum of Understanding (MOU).\" class=\"gallery-thumb img-responsive\" rel=\"newsImage\" itemprop=\"contentUrl\" loading=\"lazy\"\/><\/a><\/p>\n<p>        &#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<br \/>\n        Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions (sixth from left), and Dr. Maneesh Bagai, COO of AMPATH (standing to his right), exchange the signed Memorandum of Understanding (MOU).&#13;<br \/>\n      &#13;<\/p>\n<p>    &#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<\/p>\n<p>          <a href=\"#\" class=\"tabfocus\" role=\"button\"><img title=\"Photo: Gene Solutions and AMPATH teams\" data-getimg=\"https:\/\/mma.prnewswire.com\/media\/2786651\/Gene_Solutions_AMPATH_American_Oncology_Institute__AOI__teams.jpg?w=400\" id=\"imageid_2\" alt=\"Photo: Gene Solutions and AMPATH teams\" class=\"gallery-thumb img-responsive\" rel=\"newsImage\" itemprop=\"contentUrl\" loading=\"lazy\"\/><\/a><\/p>\n<p>        &#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n      &#13;<br \/>\n        Photo: Gene Solutions and AMPATH teams&#13;<br \/>\n      &#13;<\/p>\n<p>By combining AMPATH&#8217;s extensive diagnostic network with Gene Solutions&#8217; expertise in genomics, the partnership will enable more timely, accessible, and informative testing in key areas such as reproductive health, cancer screening, and personalized medicine.<\/p>\n<p> <b>Bringing Advanced Genomics into Everyday Practice<\/b> <\/p>\n<p>AMPATH&#8217;s nationwide infrastructure\u2014comprising over 20 satellite laboratories and more than 2,000 collection points\u2014provides a strong foundation to introduce genomics into routine diagnostics. Leveraging this reach, the newly established NGS laboratory in Hyderabad will offer:<\/p>\n<ul type=\"disc\">\n<li> <b> <a href=\"https:\/\/genesolutions.com\/our-test\/trisure-nipt\" target=\"_blank\" rel=\"nofollow noopener\">triSure NIPT<\/a> <\/b>\u00a0\u2013 A comprehensive non-invasive prenatal screening solution that provides insights into chromosomal conditions, microdeletions, and select single-gene disorders, supporting expectant parents with safe, early options for fetal health assessment and maternal well-being.<\/li>\n<li> <b> <a href=\"https:\/\/genesolutions.com\/our-test\/spot-mas\" target=\"_blank\" rel=\"nofollow noopener\">SPOT-MAS<\/a> <\/b>\u00a0\u2013 An innovative, clinically validated early cancer screening solution, designed to detect signals from 75 cancer types and subtypes using a single blood\u00a0sample\u2014providing physicians with additional tools to support early intervention.<\/li>\n<li> <b> <a href=\"https:\/\/genesolutions.com\/our-test\/k-track\" target=\"_blank\" rel=\"nofollow noopener\">K-TRACK<\/a> <\/b> <b>, <a href=\"https:\/\/genesolutions.com\/our-test\/k-4care\" target=\"_blank\" rel=\"nofollow noopener\">K-4CARE<\/a><\/b>\u2013 World-class cancer monitoring &amp; genomic profiling solutions powered by multi-omics, enabling physicians to personalize\u00a0treatment and monitor recurrence with greater confidence.<\/li>\n<\/ul>\n<p> <b>Supporting Better Patient Care Through Advanced Testing<\/b> <\/p>\n<p>The collaboration between Gene Solutions and Ampath introduces advanced diagnostic tools that support more informed clinical decisions. By offering access to innovative genomic solutions, the partnership contributes to:<\/p>\n<ul type=\"disc\">\n<li> <b>Safer, more informative prenatal screening<\/b>, empowering expectant parents with early, accurate insights into fetal health\u00a0and maternal conditions.<\/li>\n<li> <b>Earlier cancer detection<\/b>, enabling physicians to identify signals from major cancers, including breast, lung, colorectal, and head &amp; neck cancers, through a simple blood test.<\/li>\n<li> <b>Personalized cancer care<\/b>, helping oncologists tailor treatment and monitor recurrence through non-invasive genomic tools.<\/li>\n<\/ul>\n<p> <b>A Shared Vision for Accessible Precision Medicine<\/b> <\/p>\n<p>&#8220;This partnership reflects a shared vision\u2014making high-quality, science-driven genetic testing more widely available,&#8221; said <b>Dr. Nguyen Hoai Nghia<\/b>, Co-founder and CEO of Gene Solutions. &#8220;We believe that technology should be inclusive. Working with AMPATH allows us to deliver advanced solutions through a familiar and trusted healthcare network.&#8221;<\/p>\n<p> <b>Dr. Maneesh Bagai<\/b> , COO of AMPATH shared:\u00a0&#8220;We are thrilled to expand into next-generation sequencing through this strategic alliance. Together, we are redefining what&#8217;s possible in diagnostics\u2014whether it&#8217;s in maternal health, early cancer detection, or personalized oncology with patient centric approach.&#8221;<\/p>\n<p> <b>About <\/b> <b>A<\/b> <b>MPATH<\/b>\u00a0<\/p>\n<p>AMPATH\u00a0(American Institute of Pathology and Laboratory Sciences) is a trusted leader in pathology services in India, known for its adherence to international standards and excellence in clinical diagnostics. Headquartered in Hyderabad, AMPATH operates a Central Reference Laboratory and a growing network of 20+ satellite labs across India, supported by NABL (National Accreditation Board for Testing &amp; Calibration Laboratories) accreditation.<\/p>\n<p>AMPATH is part of CTSI South Asia, which also operates the American Oncology Institute (AOI) and a network of specialty hospitals, reinforcing its commitment to outcome-focused, patient-centric healthcare. Through this integrated ecosystem, AMPATH plays a pivotal role in supporting precision medicine, early disease detection, and personalized treatment strategies across oncology and other specialties.<\/p>\n<p> <b>About Gene Solutions<\/b> <\/p>\n<p>Gene Solutions is a multinational biotechnology company at the forefront of\u00a0genetic testing and research innovation\u00a0across the Asia-Pacific region. Leveraging\u00a0Next-Generation Sequencing (NGS)\u00a0and\u00a0Artificial Intelligence, the company offers a comprehensive portfolio that includes\u00a0non-invasive prenatal testing (NIPT),\u00a0cancer screening\u00a0via circulating tumor DNA (ctDNA),\u00a0genomic profiling, and\u00a0treatment monitoring.<\/p>\n<p>In addition to delivering over\u00a0two million genetic tests, Gene Solutions is recognized for its\u00a0proprietary research,\u00a0CAP-accredited laboratories, and contributions to advancing\u00a0precision medicine\u00a0through\u00a0clinical studies,\u00a0technology development, and\u00a0regional collaborations.<\/p>\n<p> Explore more information at: <b><a href=\"https:\/\/genesolutions.com\/\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/genesolutions.com\/<\/a><\/b> <\/p>\n<p>SOURCE Gene Solutions Genomics Pte Ltd<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=AE88009&amp;Transmission_Id=202510010801PR_NEWS_ASPR_____AE88009&amp;DateId=20251001\" style=\"border:0px; width:1px; height:1px;\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"HYDERABAD, India, Oct. 1, 2025 \/PRNewswire\/ &#8212; Gene Solutions, a leading genetic testing innovator in Asia, has partnered\u00a0with&hellip;\n","protected":false},"author":3,"featured_media":269127,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[140097,815,159,67,132,68],"class_list":{"0":"post-269126","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-gene-solutions-genomics-pte-ltd","9":"tag-genetics","10":"tag-science","11":"tag-united-states","12":"tag-unitedstates","13":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115298859340396008","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/269126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=269126"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/269126\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/269127"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=269126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=269126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=269126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}